Ocular Therapeutix™ to Participate in Two Investor Conferences in April
Provided By GlobeNewswire
Last update: Mar 31, 2025
BEDFORD, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced that the Company will participate in two investor conferences in April:
Read more at globenewswire.com
